Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Mar. 31, 2025
Mar. 31, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net earnings $ 91,078 $ 127,517
Adjustments to reconcile net earnings to net cash provided by operating activities:    
Depreciation and amortization 82,792 83,654
Costs recognized on sale of acquired inventory 554 550
Deferred income taxes (18,825) (29,896)
Stock-based compensation expense 36,283 30,979
Fair value adjustment to contingent consideration payable 0 (3,500)
Fair value adjustment on available-for-sale investments 0 (283)
(Gain) Loss on equity method investment 169 6,042
Asset impairment restructuring 9,961 0
Leases, net 502 1,832
Impairment (recovery) of assets held-for-sale (3,655) 6,038
Other operating activity 527 422
Change in operating assets and operating liabilities, net of acquisition:    
Trade accounts and other receivables, net 5,271 (2,611)
Inventories (11,540) (9,599)
Prepaid expenses (7,217) (1,983)
Trade accounts payable, accrued expenses, contract liabilities, and other (639) 7,160
Salaries, wages and related accruals 12,006 7,163
Income taxes receivable (7,912) 0
Net cash provided by (used in) operating activities 189,355 223,485
CASH FLOWS FROM INVESTING ACTIVITIES:    
Proceeds from sale of available-for-sale investments 1,085 23,759
Purchases of available-for-sale investments 0 (5,526)
Additions to property and equipment (26,116) (44,897)
Acquisitions, net of cash acquired 0 (169,707)
Distributions from (Investments in) Wilson Wolf 2,653 2,149
Investment in Spear Bio (15,000) 0
Proceeds from sale of assets held-for-sale 1,789 0
Net cash provided by (used in) investing activities (35,589) (194,222)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Cash dividends (38,004) (37,792)
Proceeds from stock option exercises 45,513 38,001
Re-purchases of common stock (175,674) (80,042)
Borrowings under line-of-credit agreement 38,000 225,000
Repayments of long-term debt (27,000) (186,000)
Taxes paid on RSUs and net share settlements (6,288) (21,470)
Net cash provided by (used in) financing activities (163,453) (62,303)
Effect of exchange rate changes on cash and cash equivalents (1,434) (7,616)
Net change in cash and cash equivalents (11,121) (40,656)
Cash and cash equivalents at beginning of period 151,791 180,571
Cash and cash equivalents at end of period 140,670 139,915
Supplemental disclosure of cash flow information:    
Cash paid for income taxes 55,899 44,846
Cash paid for interest $ 14,232 $ 12,393